Oric Pharmaceuticals, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Depreciation and Depletion 0.90M1.03M1.00M0.90M1.00M1.03M1.11M
Share-based Compensation 0.50M1.09M5.28M12.85M14.46M15.23M20.21M
Gains from Investment Securities 0.10M2.70M2.20M0.10M0.10M1.10M
Cash from Operations -20.68M-23.53M-45.27M-59.54M-75.14M-85.69M-112.66M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.30M-1.35M1.04M6.17M8.10M
Depreciation & Amortization (CF) 0.90M1.03M1.00M0.90M1.00M1.03M1.11M
Change in Working Capital
Change in Accured Expenses -0.41M0.99M4.30M2.93M-1.48M3.28M1.82M
Other Working Capital Changes 0.30M-0.23M2.26M-1.14M-1.03M-1.62M-0.14M
Investing Activities
Capital Expenditures 0.53M0.77M0.67M0.94M2.08M0.85M1.19M
Change in Acquisitions & Divestments 10.00M229.00M130.95M196.69M275.25M
Cash from Investing Activities -0.51M-0.77M-215.96M158.44M-109.25M-43.40M22.14M
Financing Activities
Cash from Financing Activities 38.01M70.82M250.51M49.13M25.23M85.66M126.55M
Additional items
Change in Cash 16.82M46.52M-10.71M148.03M-159.17M-43.43M36.02M
Free Cash Flow -21.21M-24.30M-45.94M-60.48M-77.22M-86.54M-113.85M
Net Cash Flow 16.82M46.52M-10.71M148.03M-159.17M-43.43M36.02M